SEARCH

SEARCH BY CITATION

References

  • Aghajanian G. K., Sprouse J. S., Sheldon P. and Rasmussen K. (1990) Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms. Ann. NY Acad. Sci. 600, 93103.
  • Baumann P. (1996) Pharmacology and pharmacokinetics of citalopram and other SSRIs. Int. Clin. Psychopharmacol. 11 (Suppl. 1), 511.
  • Bel N. and Artigas F. (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15, 243245.
  • Benmansour S., Cecchi M., Morilak D. A., Gerhardt G. A., Javors M. A., Gould G. G. and Frazer A. (1999) Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J. Neurosci. 19, 1049410501.
  • Beyer C. E., Ghavami A., Lin Q., Sung A., Rhodes K. J., Dawson L. A., Schechter L. C. and Young K. H. (2004) Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo. Brain Res. 1022, 214222.
  • Blier P., De Montigny C. and Chaput Y. (1987) Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J. Clin. Psychopharmacol. 7, 24S35S.
  • Castro E. M., Diaz A., Del Olmo E. and Pazos A. (2003) Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology 44, 93101.
  • Celeda P., Puig M. V., Casanovas J. M., Guillazo G. and Artigas F. (2001) Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABAA and glutamate receptors. J. Neurosci. 21, 99179929.
  • Chamberlain J., Offord S. J., Wolfe B. B., Tyau L. S., Wang H. L. and Frazer A. (1993) Potency of 5-hydroxytryptamine1a agonists to inhibit adenylyl cyclase activity is a function of affinity for the ‘low-affinity’ state of [3H]8-hydroxy-N,N-dipropylaminotetralin ([3H]8-OH-DPAT) binding. J. Pharmacol. Exp. Ther. 266, 618625.
  • Chaput Y., De Montigny C. and Blier P. (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 333, 342348.
  • Chen Y. and Penington N. J.(1996) Differential effects of protein kinase C activation of 5-HT1A receptor coupling to Ca2+ and K+ currents in rat serotonergic neurons. J. Physiol. 496.1, 129137.
  • Cremers T. I., Spoelstra E. N., De Boer P., Bosker F. J., Mork A., Den Boer J. A., Westerink B. H. and Wikstrom H. V. (2000) Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram. Eur. J. Pharmacol. 397, 351357.
  • Czachura J. F. and Rasmussen K. (2000) Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn Schmiedebergs Arch. Pharmacol. 362, 266275.
  • El Mansari M., Sanchez C., Chouvet G., Renaud B. and Haddjeri N. (2005) Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology 30, 12691277.
  • Geary W. A. D. and Wooten G. F. (1983) Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain. J. Pharmacol. Exp. Ther. 225, 234240.
  • Geary W. A. D., Toga A. W. and Wooten G. F. (1985) Quantitative film autoradiography for tritium: methodological considerations. Brain Res. 337, 99108.
  • Goodwin G. M. and Green A. R. (1985) A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1, and 5-HT2 receptors. Br. J. Pharmacol. 84, 743753.
  • Goodwin G. M., De Souza R. J. and Green A. R. (1985) Presynaptic serotonin receptor-mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock. Nature 317, 531533.
  • Gould G. G., Altamirano A. V., Javors M. A. and Frazer A. (2006) A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biol. Psychiatry 59, 408414.
  • Hajós M., Richards C. D., Székely A. D. and Sharp T. (1998) An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 87, 95108.
  • Hensler J. G. (2002) Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26, 565573.
  • Hensler J. G. and Durgam H. (2001) Regulation of 5-HT1A receptor-stimulated [35S]GTPgS binding as measured by quantitative autoradiography following chronic agonist administration. Br. J. Pharmacol. 132, 605611.
  • Hensler J. G., Kovachich G. B. and Frazer A. (1991) A quantitative autoradiographic study of serotonin1A receptor regulation: effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4, 131144.
  • Hervás I., Vilaró M. T., Romero L., Scorza M. C., Medgod G. and Artigas F. (2001) Desensitization of 5-HT1A autoreceptors by a low chronic fluoxetine dose. Effect of the concurrent administration of WAY 100635. Neuropsychopharmacology 24, 1120.
  • Innis R. B. and Aghajanian G. K. (1987) Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons. Eur. J. Pharmacol. 143, 195204.
  • Invernizzi R., Bramante M. and Samanin R. (1996) Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmacol. Biochem. Behav. 54, 143147.
  • Kovachich G. B., Aronson C. E., Brunswick D. J. and Frazer A. (1988) Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine. Brain Res. 454, 7888.
  • Kreiss D. S. and Lucki I. (1994) Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther. 269, 12681279.
  • Kreiss D. S. and Lucki I. (1995) Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 274, 866876.
  • Kreiss D. S., Wieland S. and Lucki I. (1993) The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience 52, 295301.
  • Le Poul E., Laaris N., Doucet E., Laporte A. M., Hamon M. and Lanfumey L. (1995) Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch. Pharmacol. 352, 141148.
  • Le Poul E., Boni C., Hanoun N., Laporte A. M., Laaris N., Chauveau J., Hamon M. and Lanfumey L. (2000) Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39, 110122.
  • Maj J. and Moryl E. (1992) Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations. J. Neural Transm. Gen. Sect. 88, 143156.
  • Molliver M. E. (1987) Serotonergic neuronal systems: what their anatomic organization tells us about function. J. Clin. Psychopharmacol. 7, 3S23S.
  • Newman M. E., Shalom G., Ran A., Gur E. and Van de Kar L. D. (2004) Chronic fluoxetine-induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635. Eur. J. Pharmacol. 486, 2530.
  • Paxinos G. and Watson C. (1998) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
  • Pejchal T., Foley M. A., Kosofsky B. E. and Waeber C. (2002) Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography. Br. J. Pharmacol. 135, 11151122.
  • Penington N. J. and Kelly J. S. (1990) Serotonin receptor activation reduces calcium current in an acutely dissociated adult central neuron. Neuron 4, 751758.
  • Penington N. J., Kelly J. S. and Fox A. P. (1993) Whole-cell recordings of inwardly rectifying K+ currents activated by 5-HT1A receptors on dorsal raphe neurons of the adult rat. J. Physiol. 469, 387405.
  • Rossi D. V., Valdez M., Gould G. G. and Hensler J. G. (2006) Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction. Int. J. Neuropsychopharmacol. 9, 393406.
  • Rossi D. V., Burke T. F., McCasland M. and Hensler J. G.(2007) Regulation of 5-HT1A receptors in the dorsal raphe nucleus (DRN) following chronic treatment with the selective serotonin reuptake inhibitor (SSRI) sertraline. Soc. Neurosci. Program No. 464.5.
  • Rutter J. J. and Auerbach S. B. (1993) Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265, 13191324.
  • Shen C., Li H. and Meller E. (2002) Repeated treatment with antidepressants differentially alters 5-HT1A agonist-stimulated [35S]GTPgammaS binding in rat brain regions. Neuropharmacology 42, 10311038.
  • Tournel G., Houdret N., Hedouin V., Deveau M., Gosset D. and Lhermitte M. (2001) High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum. J. Chromatogr. B Biomed. Sci. Appl. 761, 147158.
  • Vergé D., Daval G., Marcinkiewicz M., Patey A., El Mestikawy S., Gozlan H. and Hamon M. (1986) Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J. Neurosci. 6, 34743482.